EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Botulinum Toxin-A for treatment of Pisa syndrome: A new target muscle



Botulinum Toxin-A for treatment of Pisa syndrome: A new target muscle



Parkinsonism & Related Disorders 21(6): 669-670




(PDF emailed within 0-6 h: $19.90)

Accession: 057320631

Download citation: RISBibTeXText

PMID: 25899457

DOI: 10.1016/j.parkreldis.2015.03.027



Related references

Botulinum toxin-A for treatment of Pisa syndrome: Towards a decision-making algorithm?. Annals of Physical and Rehabilitation Medicine 59s(): E66-E66, 2016

Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease. Journal of Neurology 257(1): 139-141, 2010

Botulinum toxin for Pisa syndrome: An MRI-, ultrasound- and electromyography-guided pilot study. Parkinsonism & Related Disorders: -, 2018

Treatment of Piriformis Muscle Syndrome with Botulinum Toxin-A. Anesthesiology Abstracts of Scientific Papers Annual Meeting ( ): Abstract No A-879, 2002

Botulinum toxin type A potentiates the effect of neuromotor rehabilitation of Pisa syndrome in Parkinson disease: a placebo controlled study. Parkinsonism & Related Disorders 20(11): 1140-1144, 2015

Treatment of vocal tics in Tourettes syndrome with injection of botulinum toxin in the vocalis muscle A case report. European Journal of Neurology 7(Supplement 3): 143, November, 2000

Botulinum toxin therapy of laryngeal muscle hyperactivity syndromes: comparing different botulinum toxin preparations. European Journal of Neurology 13 Suppl 1: 36-41, 2006

An MRI evaluation of changes in piriformis muscle morphology induced by botulinum toxin injections in the treatment of piriformis syndrome. Diagnostic and Interventional Imaging 96(1): 37-43, 2015

A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 85(1-2): 101-105, March, 2000

A new target for the treatment of trigeminal neuralgia with botulinum toxin type A. Neurological Sciences 39(3): 599-602, 2017

Botulinum Toxin Type A Use in Piriformis Muscle Syndrome. American Journal of Physical Medicine & Rehabilitation 81(10): 751-759, 2002

Thoracic Outlet Syndrome Treated With Injecting Botulinum Toxin Into Middle Scalene Muscle and Pectoral Muscle Interfascial Planes: A Case Report. A&a Practice: -, 2018

Efficacy of botulinum toxin type A in treatment of different forms of focal dystonias in the Serbian population: experience of the Botulinum Toxin Outpatients Department. Vojnosanitetski Pregled 72(12): 1069-1073, 2016

Botulinum toxin type A use in piriformis muscle syndrome: a pilot study. American Journal of Physical Medicine & Rehabilitation 81(10): 751-759, 2002

The treatment of eye muscle diseases with botulinum toxin. Klinische Monatsblatter für Augenheilkunde 186(6): 453-454, 1985